Chapter 77 If you want to participate, you can give it a try!
Zhang Yang soon received a call from Dean Zhou himself.
Amidst Dean Zhou’s enthusiastic congratulations, a feeling that he couldn’t describe arose in his heart.
25% makes Dean Zhou so excited.
If he next increases the healing effect of "Ecofovir" to 50%, I wonder what Dean Zhou's reaction will be?
President Zhou’s future reaction is uncertain,
but when the first batch of clinical data of the second phase of the clinical trial of “Ecofovir” is released on the national drug clinical trial website,
then the “Starlight Project” "After the official also simultaneously released the latest clinical progress of the "QS-001" project, major pharmaceutical companies were surprised.
“Qingshan Pharmaceutical has made great progress in treating hepatitis B drugs?”
“Why so fast? Didn’t they just barely pass the first phase of clinical trials not long ago? In the past two or three months, clinical trials Achieve significant results in the second phase? ”
"This is impossible. I have seen the research and development direction of their new drug before. It is a cytotoxic drug. It has achieved a breakthrough in an instant and has a 25% cure rate for hepatitis B?!"
Everyone The pharmaceutical companies were shocked and confused. No one expected that Qingshan Pharmaceutical would come from behind and actually discover a breakthrough!
Among them, Hengrui Medicine was the most shocked.
In the office, Su Wenping stared at the news in front of him with a bitter smile on his face.
In fact, he already pays enough attention to Qingshan Pharmaceutical!
When Tsingshan Pharmaceutical's "QS-001" project first entered the second clinical phase, he immediately began to have an in-depth understanding of the drug.
In the past two months, he has roughly figured out the research and development logic of Qingshan Pharmaceutical, but he did not expect that Qingshan Pharmaceutical would achieve significant results just after he figured out the logic of the drug!
“The speed of Qingshan Pharmaceutical is too fast!”
A trace of despair flashed in Su Wenping’s eyes, but the general manager Su Lin on the side comforted him in a deep voice:
< br>“Wen Ping, it’s really impressive that they were able to find an effective compound in such a short time.”
"But this is only the first batch of clinical trial data. It is not certain whether we can maintain a cure rate as high as 25% in the future!"
"We may not have a chance!"
Su Wen Ping showed a wry smile and shook his head:
“Mr. Su, we may not have a chance.”
“Based on my understanding of Qingshan Pharmaceutical, they should have updates and updates soon. Significant results! ”
Su Lin looked startled.
Just when domestic pharmaceutical companies were surprised, the news also spread to the United States and to Gilead.
“I have to say that the idea of this Chinese pharmaceutical company Qingshan Pharmaceutical is indeed very novel.”
“Enter liver cells in a cytotoxic manner, thereby allowing hepatocytes infected with hepatitis B virus to Rapid death to achieve the purpose of killing the hepatitis B virus. "
"But the cure rate of 25% is not enough. It seems that they have not found the right compound."
"John, we have to speed up the progress. This Chinese pharmaceutical company may be our strong competitor."
The announcement of the second phase clinical data of QS-001 of Qingshan Pharmaceutical surprised the pharmaceutical companies. Fortunately, there is currently a small amount of clinical phase II data, and it is difficult to say whether the 25% cure rate can be maintained.
Secondly,
Even if there is a 25% cure rate, coupled with the cytotoxicity of the drug itself, there is a high probability that it will not become a true first-line drug.
After being surprised, major pharmaceutical companies felt tremendous pressure, and at the same time they really began to pay close attention to the subsequent research and development progress of QS-001 of Qingshan Pharmaceutical.
The news soon spread to the Hepatitis B forum.
Huang Yi, as the owner of a hepatitis B bar, is not actually a hepatitis B patient.
However.
After seeing the significant results of the new drug "QS-001" of Qingshan Pharmaceutical released by the organizers of the "Starlight Project", he couldn't help but feel excited. "Good news! There is a 25% chance of curing hepatitis B!"
"We must move it to Hepatitis B as soon as possible, and let everyone see the latest results! Now everyone should have some confidence, right?"
The excited Huang Yi quickly moved the post to the post bar. He also specially chose a rather promising title:
[Good news! The latest hepatitis B drug from domestic pharmaceutical company Tsingshan Pharmaceutical achieved a 25% cure rate in the second phase of clinical trials! 】
As soon as the post was published this time, the number of views exceeded 200 in just a few minutes. He refreshed the post excitedly, hoping to see the enthusiastic discussions among the friends.
However, one minute, five minutes, ten minutes passed, except for a few words of "Thanks for the portage" in the post, there were almost no friends discussing this matter.
Huang Yi was so surprised that he started to like the post non-stop, hoping that more friends would see this message!
But!
In the next half hour, no matter how hard he tried, very few people responded!
After an hour, the popularity of the post began to decline, and it was gradually crowded behind by other posts!
Looking at the situation in front of him, Huang Yi was extremely disappointed and found it difficult to understand.
In the past, people did not pay attention to the "Starlight Project" because they had no hope and because they had become desperate after being disappointed again and again!
And now!
Isn’t hope just around the corner?
Why is everyone still so indifferent and so irrelevant? ! Are you even no longer interested in discussing it? !
Do they really not care?
"Hey!"
Huang Yi sighed heavily.
In the next few days, his posts completely disappeared. After seven or eight pages from the homepage, he completely lost popularity.
Not to mention his topic posts, as the "Starlight Project" was launched less than half a year ago, the entire Hepatitis B forum's posts about the Starlight Project have almost disappeared.
Posts about "Starlight Project" and new drugs in the hepatitis B forum seem to be uninteresting. Under such indifference, unknowingly, the second batch of clinical trials of Qingshan Pharmaceutical's "QS-001" The data for the second phase are also published on the official website.
The results were almost the same as the last time. There were 15 patients and 8 test subjects in this batch. Two of the test subjects successfully turned negative, and the cure rate stabilized at 25%.
This time Huang Yi noticed the official announcement immediately.
After a slight hesitation, he still moved to the Hepatitis B bar.
However, compared to the last time, he no longer has too many expectations. He doesn’t know what these hepatitis B patients are thinking, and how they view the "Starlight Project" and innovative hepatitis B drugs.
Sure enough.
Half an hour after the post was posted, the post titled [Qingshan Pharmaceutical Phase II Clinical Data Updated: New Drug Still Maintains 25% Cure Rate] still failed to arouse discussion among patients.
Just when he was about to quit the post bar in despair, a familiar ID suddenly appeared in the comments.
【The Chic Prodigal Son】:
“The data is true, I just participated in the second batch of clinical trials of Qingshan Pharmaceutical.”
“However, I am not cured , I am 75% of them!”
"Moreover, this drug has very strong side effects. I took it for two months, and I felt exhausted, nauseous, and almost unable to do anything for two months. Moreover, the transaminases were always high, over 200!"
"Those who want to participate can give it a try!
What I can guarantee is that the 25% cure rate is real!"
What Huang Yi didn't expect was that this comment Not long after I left, more and more people started discussing the post!
……
PS: Thanks to the reader I’m Still Lonely for the generous reward of 500 coins
(End of this chapter)